En direct

Le Centre de Recherche en Cancérologie de Marseille fête ses 50 ans ! -

04 2019 British journal of cancer

ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer.


Daulat AM, Finetti P, Revinski D, Silveira Wagner M, Camoin L, Audebert S, Birnbaum D, Kodjabachian L, Borg JP, Bertucci F


Triple-negative breast cancers (TNBC) are poor-prognosis tumours candidate to chemotherapy as only systemic treatment. We previously found that PRICKLE1, a prometastatic protein involved in planar cell polarity, is upregulated in TNBC. We investigated the protein complex associated with PRICKLE1 in TNBC to identify proteins possibly involved in metastatic dissemination, which might provide new prognostic and/or therapeutic targets.

Lire l‘article